Key result
Hepatic steatosis shows no correlation with carotid IMT in type 2 diabetes.
Why the study?
Is hepatic steatosis associated with increased carotid intima-media thickness in patients with type 2 diabetes?
Population
101 patients with type 2 diabetes mellitus
Comparison
Hepatic steatosis vs Patients without hepatic steatosis
Design
Cross-sectional
Authors
Loading...
No association in this cross-sectional study; leaves open whether hepatic steatosis influences atherosclerosis progression or outcomes in type 2 diabetes.
Cross-Sectional (n=101)
Is hepatic steatosis associated with increased carotid intima-media thickness in patients with type 2 diabetes?
Effect estimate: r = -0.03
p-value: p=0.75
In patients with type 2 diabetes, nonalcoholic fatty liver disease is not associated with increased carotid intima-media thickness, suggesting it may not be an independent determinant of atherosclerosis in this population.
Petit et al. (2009) conducted a cross-sectional in Type 2 diabetes mellitus (n=101). Hepatic steatosis vs. Without hepatic steatosis was evaluated on Carotid intima-media thickness (IMT) (r = -0.03, p=0.75). Hepatic steatosis was not correlated with carotid intima-media thickness in patients with type 2 diabetes (r = -0.03; P = 0.75).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: